VintaBio presented promising new data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, ...

VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its ...

VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and productivity of its proprietary ...

The data, featured in a poster session on May 15, demonstrate that VintaProcess™ enables enrichment of full capsids at harvest by extending viral vector production using a novel perfusion ...